SAMN10254555
External Id
dbGaP
INSDC center name
2018-10-17T16:13:11.400Z
INSDC first public
2019-04-25T10:19:12.350Z
INSDC last update
SRS4330287
INSDC secondary accession
live
INSDC status
Generic
NCBI submission model
Generic.1.0
NCBI submission package
SRS4330287
SRA accession
RNA
analyte type
NCI_Alisertib_PC
biospecimen repository
WCM192_1_N_RNA_Tumor
biospecimen repository sample id
Prostate
http://purl.obolibrary.org/obo/UBERON_0002367
body site
phs001666
gap_accession
1
gap_consent_code
HMB-PUB
gap_consent_short_name
3312224
gap_sample_id
2765726
gap_subject_id
Tissue : Neuroendocrine Prostate Cancer
histological type
Yes
is tumor
Homo sapiens
http://purl.obolibrary.org/obo/NCBITaxon_9606
organism
male
http://purl.obolibrary.org/obo/PATO_0000384
sex
Case Set
study design
Adenocarcinoma
http://www.ebi.ac.uk/efo/EFO_0000571
study disease
Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer
study name
Yes
subject is affected
WCM192_1_N_RNA_Tumor
submitted sample id
WCM192
submitted subject id
NCI_Alisertib_PC
submitter handle
Adenocarcinoma tumor RNA sample from Prostate of a human male participant in the dbGaP study Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration Resistant and Neuroendocrine Prostate Cancer
title